not tagged
not tagged
['pancreatic', 'gastric', 'gicsm', 'chimeric antigen receptor ', '#gi']
treatment with a claudin18.2 specific chimeric antigen receptor t-cell therapy has demonstrated either a response or stable disease in patients with heavily pretreated advanced gastric and pancreatic adenocarcinoma. #gicsm #asco22 
Oncology news and insights from leading researchers and cancer centers.